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A B S T R A C T
Streptococcal toxic shock syndrome (STSS) can be deﬁned as a septic shock syndrome resulting from
infection with toxin-producing group A streptococci (GAS). STSS can sporadically present as primary
peritonitis in previously healthy persons. Signs of STSS are non-speciﬁc and patients generally present
with ﬂu-like symptoms and can develop a life-threatening toxic shock syndrome in just a few hours.
Diagnosis is mainly by a combination of physical examination, laboratory/culture results, and exclusion
of surgical causes by means of imaging modalities and/or surgical exploration. GAS remain penicillin-
sensitive and most are clindamycin-sensitive. Prompt supportive treatment, possibly together with
high-dose intravenous immunoglobulins, is crucial.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Lanceﬁeld group A b-hemolytic Streptococcus (GAS) also
known as Streptococcus pyogenes, is known to cause several
diseases of varying clinical severity.Well-described and frequently
observed suppurative infections caused by S. pyogenes are
pharyngitis and skin infections like erysipelas and impetigo, with
necrotizing fasciitis being the most severe presentation. Other
dramatic manifestations are puerperal sepsis and the rare
streptococcal toxic shock syndrome (STSS), which resembles the
staphylococcal toxic shock syndrome. In addition, non-suppura-
tive infections, such as rheumatic fever and acute glomerulone-
phritis, have been associated with GAS.
Virulence is determined by the presence or absence of
encapsulation, adhesion proteins, toxin production, and host
factors.1,2
Several epidemiological studies have indicated that GAS
infections are increasing in incidence and are becoming more
severe in presentation.3,4
STSS can sporadically present in previously healthy people as
primary peritonitis, with severe septic shock and multiple organ
failure emerging in just a few hours.5 A few such cases have been
described thus far, occurring especially in women of reproductive* Corresponding author. Current address: University Hospital Brussels, Belgium.
E-mail address: alwintilanus@hotmail.com (A.M.R. Tilanus).
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doi:10.1016/j.ijid.2009.07.014age; an associationwith the female genital tract has therefore been
speculated.
Here we present a case of STSS and brieﬂy review potential
characteristics, difﬁculties in diagnosis, and treatment options for
this potentially fatal syndrome.
2. Case report
A 39-year-old woman was referred to our tertiary care
university hospital from a nearby hospital. The patient had
presented there with ‘ﬂu-like’ symptoms including headache,
fever (up to 38.5 8C), and anorexia. Two days later she developed
cold shivers, nausea with vomiting, and diarrhea (about 10 times a
day without blood or mucus). Furthermore she complained of an
abrupt onset severemuscle pain in the rightmedial thigh, radiating
to the right lower abdomen, which prevented her from walking
within hours of onset. There was no history of cough or dyspnea in
the days before presentation. Her children had had remarkably red
lips for about 2 weeks and had suffered for some days from sore
throat.
Her last menstruation had been two weeks ago and she had
normal regular menses. There was no history of abnormal vaginal
discharge or dysuria, although she claimed that micturition was
less than normal the day before presentation. Her medical history
was unremarkable, except for an appendectomy in 1984, and her
family history was unremarkable. She is a general physician and
mother of four children. There was no recent travel history orses. Published by Elsevier Ltd. All rights reserved.
Table 1
Laboratory results
Characteristic On admission (nearby hospital)
Blood count
Hemoglobin 5.7 mmol/l
Mean corpuscular volume (MCV) 74 ﬂ
Leukocytes 2.8109/l
Neutrophils Normal
Rods in the white cell differentiation 38%
Lymphocytes 0.06109/l
Thrombocytes 130109/l
C-reactive protein (CRP) 296 mg/l
Urea 11.6 mmol/l
Creatinine 159 mmol/l (MDRD 31 ml/min)
Liver biochemistry
Bilirubin 21.3 mmol/l
Aspartate aminotransferase (AST) 108 mmol/l
Alanine aminotransferase (ALT) 65 mmol/l
Blood gas analysis
Ph 7.38
pCO2 26 mmHg
HCO3
 15 mmol/l
Base excess (BE) 10 mmol/l
Lactate 5.3 mmol/l
Urine No abnormalities
MDRD, Modiﬁcation of Diet in Renal Disease Study equation.
Figure 1. Thickened psoasmuscle (P) and enlarged adnexal regionwith a prominent
cyst (arrow) on the right. Compare with normal psoas muscle (P) on the left.
Figure 2. The left ovary (O) appears normal. Ascites in the pelvic cavity (arrows). U:
uterus.
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wounds, although she claimed that she had a long history of
onychomycosis of the toes on both feet, for which she visited the
chiropodist now and then. She did not take any medication.
On physical examination, she was seen to be ill looking and
hypotensive, with resting blood pressure of 68/50mmHg and pulse
104 bpm. Her temperature was 38.5 8C and arterial oxygen
saturation 96% without supplemental oxygen. Skin turgor was
diminished, and dry mucous membranes were observed. Lymph
nodes were not palpable.. Heart sounds were normal and an
examination of the lungs revealed somewheezes without crackles.
The abdomen showed a diffuse exanthema, sparse peristalsis,
normal tympania, andwas soft on palpationwithout rebound pain.
The liver and spleen were not palpable. There was a severe pain
radiating from the right medial thigh to the right inguinal region
and right lower quadrant of the abdomen. The extremities showed
no erythema or edema. Raising the right leg was extremely painful,
indicating a ‘positive psoas’ sign. An electrocardiogram showed a
sinus tachycardia without further abnormalities. Laboratory
results are summarized in Table 1.
Due to the suspicion of pelvic inﬂammatory disease (PID), a
consultation with a gynecologist was arranged. A vaginal digital
examination revealed no abnormalities and no discharge. On initial
transvaginal ultrasound (TV US), the right ovary appeared
enlarged. The left adnexal region showed no abnormalities. No
ﬂuid collections were seen in the Douglas cavity. A computed
tomography (CT) scan of the thorax and abdomen 24 h after the
initial TVUS showed a thickened right psoasmuscle surrounded by
fatty inﬁltration and a large amount of free ﬂuid in the peritoneal
cavity (Figures 1 and 2). The patient was admitted to the intensive
care unit (ICU) and received resuscitation ﬂuids, inotropic support,
and intravenous antibiotics (amoxicillin–clavulanic acid 1.2 g four
times daily, clindamycin 600 mg three times daily, and gentamicin
240 mg once daily). The patient was subsequently transferred to
our hospital for further treatment.
An abdominal ultrasound was repeated, which conﬁrmed the
ﬁndings on the CT scan. In addition, the slightly enlarged right
ovary showed normal vascularization. Peritoneal ﬂuid (ascites)
was increased and was present in the upper and lower abdomen.
No abnormalities were seen in the right inguinal region. A
pregnancy test was negative. Cultures of blood, vaginal andabdominal ﬂuid were taken. With the differential diagnosis of an
acute adnexitis, the antibiotic regime was switched to cefuroxime
750 mg four times daily, metronidazole 500 mg three times daily,
and ciproﬂoxacin 400 mg twice daily, while awaiting culture
results. The patient also received hydrocortisone 100 mg three
times daily. Our patient’s condition deteriorated rapidly and
progressed within hours to a state of multi-organ failure
comprising circulatory failure, acute kidney injury (AKI), acute
respiratory distress syndrome (ARDS), coagulopathy (including
thrombocytopenia), and lactic acidosis. A pulmonary artery
catheter (PAC) was inserted showing a central venous pressure
(CVP) of 19mmH2O, cardiac output 8.0 l/min, ejection fraction 33%,
wedge pressure 21 mmH2O, and a central venous blood saturation
(SCVO2) of 75%. Chest X-ray showed bilateral pulmonary con-
solidations consistent with ARDS. Because of the high CVP, an
esophageal echocardiography was performed, showing no
abnormalities. An explorative laparotomy was performed and
showed no abnormalities apart from the ascites. Analysis of the
ascites revealed 0.7  109/l leukocytes and 0.6  109/l polymor-
phonuclear cells, indicating reactive peritonitis. The blood culture
showed Lanceﬁeld group A b-hemolytic streptococci (GAS). The
antibiotic regimewas narrowed to benzyl penicillin 2million IU six
times daily and clindamycin 600 mg three times daily. Intravenous
immunoglobulins (IVIG; three consecutive days at 1 g/kg of body
weight on day 1 and 0.5 g/kg on days 2 and 3) were administered.
The patient made an excellent recovery and was admitted to
our ICU for 8 days, of which she was intubated for 6 days. Several
days following admission, mild desquamation of both feet was
Table 2
Overview of published articles on GAS primary peritonitis
Author, year Age Sex Pain in
extremity
Diarrhea Signs of
peritonitis
Rash/
desquamation
Imaging Leukocyte
count
Medical history Surgery Possible
focus
Children
ill?
Cultures Antibiotics IgG
Graham
et al. 1995 [14]
39 F No Yes Yes Rash+erythema
nodosum
Chest-X+X-abdomen:
no abnormalities
Leukocytosis,
anemia
Not relevant Laparotomy:
ascites
Aerosol? Yes,
pharyngitis
Perineum:
GAS (T3/M3/R3)
Cefotaxime+
metronidazole
! benzyl
penicillin !
amoxicillin
No
Moskovitz
et al. 2000 [15]
39 F ? Yes Yes ? ? Leukocytosis Not relevant Yes, not speciﬁed.
Peritonitis: scant
cloudy peritoneal
ﬂuid. Appendix
mildly inﬂamed
Aerosol? Yes,
pharyngitis
Blood: GAS;
Gram stain
peritoneal ﬂuid:
rare Gram-positive
cocci; vaginal
swab: GAS
Levoﬂoxacin +
metronidazole !
ceftriaxone+
sulbactam
sodium/ampicillin
sodium
?
Vuilleumier
and Halkic
2001 [17]
33 F ? Yes Yes ? ? Leukopenia 2 months
post-partum
Laparotomy: pus
+mild hyperemia
of the ﬁmbriae
Genital
tract?
? Peritoneal,
endometrium
and blood: GAS
Imipenem !
clindamycin +
meropenem
Yes
Gavala et
al. 2002 [18]
40 M Yes No Yes Erythema CT-abdomen:
peritoneal and
extra-peritoneal
ﬂuid collections
‘Lab signs
of inﬂammation’
? Laparotomy (2) ? ? Pus peritoneum:
GAS+E. coli
Metronidazole +
netilmicin +
tazocin
No
Kanetake
et al. 2004 [20]
40 M Yes Yes Yes Rash+erythema
+desquamation
X-abdomen: dilated
small bowel loops,
no free air,
conﬁrmed
by CT-abdomen
and US
Leukopenia ? Laparotomy:
ascites
Aerosol? Yes,
pharyngitis
Ascites: GAS
(T-type 22)
Yes, but not
speciﬁed
Yes
Brivet et
al. 2005 [24]
58 F ? ? Yes Lumbar rash CT-abdomen:
minimal bilateral
pleural and
intraperitoneal
effusions
? Appendectomy,
salpingitis,
miscarriages
Laparoscopy:
peritonitis
? ? Blood: GAS Amoxicillin–
clavulanic acid +
gentamicin
No
Brivet et
al. 2005 [24]
82 F ? Yes Yes ? Chest-X: bilateral
pleural effusion
+mass of the right
lung. Abdominal-CT:
mild intraperitoneal
effusion
Leukocytosis,
anemia
Epilepsy, colorectal
villous adenomas,
progressive weight
loss, heavy tobacco
exposure, and tooth
abscess 12 days
before admission
No ? ? Blood: GAS Amoxicillin–
clavulanic acid
No
Saha et
al. 2006 [21]
23 F No Yes Yes No CT abdomen+US:
tubo-ovarian abscess
with free ﬂuid
Normal
leukocyte
count
Not relevant Laparotomy:
ascites + inﬂamed
fallopian tubes;
no abscess
? ? Blood: GAS Ceftriaxone+
metronidazole
+oral doxycycline
! penicillin +
clindamycin +
ciproﬂoxacin +
doxycycline
No
van Lelyveld-Haas
et al. 2008 [22]
28 F No No No No ? Leukocytosis Not relevant Laparotomy: pus ? ? Peritoneal pus:
GAS; blood: GAS;
vaginal swab: GAS
Tazocin !
benzyl penicillin
?
Van Den Bossche
et al. 2008 [23]
52 F ? Yes Yes Rash/
desquamation
CT-abdomen: free
ﬂuid, no
signs of perforation
Leukocytosis ‘Acute laryngitis’ a
few days prior
to admission
Laparotomy: pus Larynx? ? Peritoneal pus:
GAS; blood: GAS
Yes, penicillin,
erythromycin and
clindamycin?
(not further
speciﬁed)
Yes
GAS, group A Streptococcus; X, X-ray; CT, computed tomography; US, ultrasound.
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clindamycin for 7 days.
3. Discussion
Most of the described cases of STSS have occurred in
association with prior disease and procedures like child birth,
skin infections, or surgical interventions.5–10 Only a few cases of
STSS in previously healthy adults have been described present-
ing as a primary peritonitis in which the source of the GAS
infection remained unknown. Some are brieﬂy reviewed here
(Table 2).11–24
Our patient presented with ﬂu-like symptoms, diarrhea, and
severe pain in the right inner thigh with a positive psoas sign.
Diagnosis was difﬁcult, as a gynecological cause was suspected,
based on the ultrasound ﬁndings of an enlarged and painful right
adnexal region. An urgent laparotomywas performed and revealed
massive purulent ascites without other abnormalities.
Diagnosis of GAS primary or secondary peritonitis can be
difﬁcult. It is ﬁrst important to determine whether the sepsis is a
result of a surgical cause (e.g. perforation, ischemia, bowel
obstruction, etc.) or not. Brivet et al. advocated that an
abdominal CT scan is a sensitive diagnostic tool that can avoid
unnecessary laparoscopies: when no convincing abnormalities
are found on abdominal CT scan, a conservative supportive
approach can be relied upon.24 However, Farooq and Ammori
described a patient with primary bacterial peritonitis diagnosed
at laparoscopy and claimed that laparoscopy could well be used
as a diagnostic tool in the management of generalized
peritonitis.25 Preference for laparoscopy or laparotomy should
be established on an individual basis. We chose laparotomy
because of a suspicion of a pathology primarily located in the
right psoas muscle or adnexal region.
Analyzing the case reports of primary peritonitis (Table 2)
caused by GAS, one can see a clear preponderance of females in the
age category 30–40 years, and an association between the female
genital tract and a possible bacterial translocation has therefore
been speculated.15,17 Findings on CT scan of a thickened right psoas
muscle and adnexal region in our patient may support the
hypothesis of bacterial translocation through the female genital
tract. The painful right thigh could be explained by the
inﬂammatory reaction of the right psoas muscle (with thickening
on CT scan) in the direct surrounding of the right adnexal region,
which was possibly the primary site of bacterial translocation and
growth.
Severe pain in a lower extremity was also noted in the cases
described by Gavala et al.18 and Kanetake et al.20 However, the
sensitivity and speciﬁcity of severe pain in an extremity is difﬁcult
to determine, since this has not been described in several case
reports. Interestingly, as in our case, some authors noted that the
children of the patient had suffered some form of pharyngitis prior
to or at the time that the patient had developed symptoms.14,15,20
The possible source of entry in our patient remains speculative, but
could be related to the onychomycosis or the pharyngitis of her
children.
In contrast to several other patients who presented with
leukocytosis, our patient presented with leukocytopenia. Leu-
kocytopenia was also noted in the cases of Kanetake et al.20 and
Vuilleumier and Halkic.17 The explanation for this is not clear,
but it could be speculated that this is related to the strain
involved and the toxin/cytokine proﬁle. Anemia with elevated
bilirubin was probably related to hemolysis caused by bacterial
hemolytic enzymes. Thrombocytopenia might well be explained
by the occurrence of disseminated intravascular coagulation
(DIC), which frequently occurs in severe sepsis. In addition,
Shannon et al. hypothesized that the M1 protein of S. pyogenestriggers immune-mediated platelet (IgG) activation and throm-
bus formation.26 Most cases had no relevant medical history and
had undergone an abdominal CT and surgical intervention
(diagnostic laparotomy) after being treated with broad-spec-
trum antibiotics. Analyzing the cases in Table 2, it could be
cautiously concluded that there is currently no consensus
regarding the diagnostic approach and treatment (antibiotics).
We used a combination therapy of clindamycin and penicillin,
not because of synergistic effects. There is evidence that
clindamycin is more effective than penicillin, but penicillin is
added to overcome the small possible risk of clindamycin-
resistant strains.27
In our patient, the GAS infection was conﬁrmed by positive
blood culture. Culture of ascites, taken after antimicrobial therapy
had been administered, remained negative. Together with the
above-mentioned clinical symptoms and laboratory results, our
patient fulﬁlled the proposed criteria for STSS.28
We administered high dose steroids, since severe STSS can be
associated with lethal bilateral adrenal hemorrhage (Waterhouse–
Friderichsen syndrome).29
Evidence for the use of IVIG in the management of STSS is
scarce, and since it is a rare disease, it has been difﬁcult to
conduct a randomized controlled trial. Kaul et al. compared 21
patients with STSS who received 2 g IVIG/kg (single dose) with
32 control STSS patients. Though not randomized and therefore
bias-sensitive, the authors concluded carefully that mortality
after 30 days was signiﬁcantly lower in the IVIG group.
Furthermore, IVIG therapy enhanced the ability of patient
plasma to neutralize bacterial mitogenicity and reduced T-cell
production of interleukin-6 (IL-6) and tumor necrosis factor-a
(TNF-a).30 Darenberg et al. performed a multicenter, double-
blind, placebo-controlled trial with IVIG in STSS patients.
However, because of slow patient recruitment the trial was
terminated prematurely. In total, only 21 patients (10 IVIG
versus 11 placebo patients) were analyzed. IVIG was provided
intravenously for three consecutive days at 1 g/kg of body
weight on day 1 and 0.5 g/kg on days 2 and 3. A signiﬁcant
decrease in the sepsis-related organ failure assessment (SOFA)
score at days 2 and 3 was noted in the IVIG group.31 Norrby-
Teglund et al. reviewed the use of IVIG in severe GAS infections.
Available data suggest that IVIG is probably effective against GAS
strains of varying serotypes and with different superantigen
production. Potential mechanisms of IVIG are probably related to
increased phagocytosis (via opsonizing anti-M antibodies),
neutralization of exotoxins (superantigens), and suppression
of pro-inﬂammatory responses.32
To summarize, the current best practice treatment of STSS is
probably a combination of supportive therapy (ﬂuids, inotropes,
vasopressors), clindamycin/penicillin, and IVIG. In addition,
corticosteroids and drotrecogin-alpha (recombinant activated
protein C) can be administered.
Conﬂict of interest: No conﬂict of interest to declare.
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